Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will sponsor tennis players participating in The Championships, Wimbledon 2024 to spotlight its advanced Sports Medicine portfolio alongside some of the greatest athletes in the world. Smith+Nephew endeavours to help people live their ‘Life Unlimited’ by aiding in their recovery from injury and get them back to doing what they love. Click to play video - Smith+Nephew Proud Player Sponsor at The Championshi
As global markets exhibit caution and the FTSE 100 faces downward pressure, investors are keenly observing economic indicators and geopolitical events that could influence market dynamics. In such a climate, identifying undervalued stocks in the UK market requires a nuanced understanding of both macroeconomic factors and individual company fundamentals.
This FTSE stock’s been crushed if not quite left for dead. However, Edward Sheldon believes it's capable of a big rebound at some stage. The post Down 50%, this FTSE dividend stock looks like a steal to me appeared first on The Motley Fool UK.